These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17699204)

  • 1. Peritoneal inflammation and high transport status.
    Khanna R
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):167-9. PubMed ID: 17699204
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between peritoneal leukocyte count, fluid cultures, and clinical results in peritonitis among peritoneal dialysis patients: is there a geographic or ethnic difference?
    Ozturk S; Sar F; Altas K; Uzun S; Yazici H; Bozfakioglu S; Kazancioglu R
    Adv Perit Dial; 2009; 25():32-40. PubMed ID: 19886314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal membrane failure in peritoneal dialysis patients.
    Krediet RT; Van Esch S; Smit W; Michels WM; Zweers MM; Ho-Dac-Pannekeet MM; Struijk DG
    Blood Purif; 2002; 20(5):489-93. PubMed ID: 12207100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical implications of peritoneal transport].
    Teixidó J
    Nefrologia; 2000; 20 Suppl 2():53-61. PubMed ID: 10822739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the human peritoneum after peritoneal dialysis].
    Hort W; Benner W
    Med Welt; 1967 Nov; 45():2571-5. PubMed ID: 5609203
    [No Abstract]   [Full Text] [Related]  

  • 6. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients.
    Van Biesen W; Van der Tol A; Veys N; Dequidt C; Vijt D; Lameire N; Vanholder R
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):269-74. PubMed ID: 17699216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High peritoneal transport: a blessing or curse?
    Voinescu CG; Khanna R; Nolph KD
    Adv Perit Dial; 2002; 18():106-11. PubMed ID: 12402599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis.
    Lin WT; Tsai CC; Chen CY; Lee WJ; Su CC; Wu YJ
    Ren Fail; 2008; 30(8):772-7. PubMed ID: 18791950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneum: a noble membrane in long-term dialysis treatment.
    Barone RJ; Campora MI; Gimenez NS; Ramirez L; Santopietro M; Grbavac D; Pattin M; Panese SA
    Adv Perit Dial; 2009; 25():80-4. PubMed ID: 19886323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the peritoneal interstitium and their effect on peritoneal transport.
    Flessner MF
    Perit Dial Int; 1999; 19 Suppl 2():S77-82. PubMed ID: 10406498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
    Yang WS; Tsai TJ; Shih CL; Huang JW; Chuang HF; Chen MH; Fang CC
    Blood Purif; 2009; 28(1):69-74. PubMed ID: 19439926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis.
    Garosi G; Di Paolo N
    Perit Dial Int; 2001; 21(4):417-8. PubMed ID: 11587411
    [No Abstract]   [Full Text] [Related]  

  • 13. What are the problems with using the peritoneal membrane for long-term dialysis?
    Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S
    Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949
    [No Abstract]   [Full Text] [Related]  

  • 14. Nocardia asteroides peritoneal dialysis-related peritonitis: a case of successful treatment and return to peritoneal dialysis.
    Kendrick-Jones J; Ratanjee SK; Taylor SL; Marshall MR
    Nephrol Dial Transplant; 2008 Aug; 23(8):2693-4. PubMed ID: 18495741
    [No Abstract]   [Full Text] [Related]  

  • 15. A reevaluation of empiric therapy for peritoneal dialysis-related peritonitis.
    Zelenitsky S; Ariano R; Harding G
    Am J Kidney Dis; 2004 Sep; 44(3):559-61. PubMed ID: 15332230
    [No Abstract]   [Full Text] [Related]  

  • 16. The outcome for pediatric patients on peritoneal dialysis.
    Acar B; Yalcinkaya F; Cakar N; Yüksel S; Ozçakar ZB; Uncu N; Kara N; Elhan AH; Ekim M
    J Nephrol; 2008; 21(3):394-9. PubMed ID: 18587728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of peritoneum during dialysis.
    Oreopoulos DG; Izatt S
    Br Med J; 1973 Sep; 3(5880):592-3. PubMed ID: 4726941
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.
    Chow KM; Szeto CC; Cheung KK; Leung CB; Wong SS; Law MC; Ho YW; Li PK
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):768-73. PubMed ID: 17699285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
    Mizuno M; Ito Y; Hepburn N; Mizuno T; Noda Y; Yuzawa Y; Harris CL; Morgan BP; Matsuo S
    J Immunol; 2009 Jul; 183(2):1403-12. PubMed ID: 19553534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-reactive protein, acute or intermediate phase reactant in peritoneal dialysis patients with peritonitis?].
    Fraile P; García-Cosmes P; Lerma JL; Tabernero JM
    Nefrologia; 2007; 27(3):393. PubMed ID: 17725466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.